Your browser doesn't support javascript.
loading
Requirement for CDK6 in MLL-rearranged acute myeloid leukemia.
Placke, Theresa; Faber, Katrin; Nonami, Atsushi; Putwain, Sarah L; Salih, Helmut R; Heidel, Florian H; Krämer, Alwin; Root, David E; Barbie, David A; Krivtsov, Andrei V; Armstrong, Scott A; Hahn, William C; Huntly, Brian J; Sykes, Stephen M; Milsom, Michael D; Scholl, Claudia; Fröhling, Stefan.
Afiliación
  • Placke T; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany; German Consortium for Translational Cancer Research, Heidelberg, Germany;
  • Faber K; Department of Internal Medicine III, Ulm University, Ulm, Germany;
  • Nonami A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
  • Putwain SL; Department of Haematology, Cambridge Institute of Medical Research, and Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom;
  • Salih HR; German Consortium for Translational Cancer Research, Heidelberg, Germany; Department of Hematology and Oncology, Eberhard Karls University, Tübingen, Germany;
  • Heidel FH; Department of Hematology and Oncology, Otto von Guericke University, Magdeburg, Germany;
  • Krämer A; German Consortium for Translational Cancer Research, Heidelberg, Germany; Clinical Cooperation Unit Molecular Hematology and Oncology, German Cancer Research Center, and Department of Internal Medicine V, Ruprecht Karls University, Heidelberg, Germany;
  • Root DE; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;
  • Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;
  • Krivtsov AV; Leukemia Center, Human Oncology and Pathogenesis Program and Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY;
  • Armstrong SA; Leukemia Center, Human Oncology and Pathogenesis Program and Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY;
  • Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;
  • Huntly BJ; Department of Haematology, Cambridge Institute of Medical Research, and Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom;
  • Sykes SM; Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, PA; and.
  • Milsom MD; Heidelberg Institute for Stem Cell Technology and Experimental Medicine and Division of Stem Cells and Cancer, Experimental Hematology Group, German Cancer Research Center, Heidelberg, Germany.
  • Scholl C; Department of Internal Medicine III, Ulm University, Ulm, Germany;
  • Fröhling S; Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany; German Consortium for Translational Cancer Research, Heidelberg, Germany;
Blood ; 124(1): 13-23, 2014 Jul 03.
Article en En | MEDLINE | ID: mdl-24764564
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Quinasa 6 Dependiente de la Ciclina / Proteína de la Leucemia Mieloide-Linfoide Límite: Animals / Humans Idioma: En Revista: Blood Año: 2014 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Quinasa 6 Dependiente de la Ciclina / Proteína de la Leucemia Mieloide-Linfoide Límite: Animals / Humans Idioma: En Revista: Blood Año: 2014 Tipo del documento: Article